Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted CAGR for the Pertussis Vaccine Market Over the Forecast Period of 2025 to 2034?

In recent times, the market size of the pertussis vaccine has experienced consistent growth. The market is expected to expand from a valuation of $5.5 billion in 2024 to $5.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.1%. The increase witnessed during the historical period can be credited to factors such as disease prevalence, immunization initiatives, pediatric vaccinations, and regulatory authorizations.

In the coming years, a consistent increase in size is anticipated for the pertussis vaccine market. It’s estimated that this market will expand to $6.62 billion by 2029, with a compound annual growth rate (CAGR) of 3.7%. Various factors contributing to this expected growth in the forecast period include booster vaccinations, maternal immunization, healthcare worker immunization, and worldwide health initiatives. Looking ahead to the forecast period, main trends to watch out for include personalized immunization schedules, combination vaccines, equality initiatives for vaccines, and the application of digital health in immunization.

What Key Drivers Are Accelerating the Growth of the Pertussis Vaccine Market During the Forecast Period?

The upward trend in childbirth rates is propelling the expansion of the pertussis vaccine market. The process of birthing a child, referred to as childbirth, marks the end of a pregnancy and the start of a new life outside the uterus. The pertussis vaccine, which shields children from whooping cough and other dangerous diseases, is typically administered to children. As an illustration, the Centers for Disease Control and Prevention, a public health organization in the US, reported a 1% increase in registered births in the United States as of January 2023, bringing the total to 3,664,292 births. This upsurge in childbirth rates is fueling the pertussis vaccine market growth.

Pertussis Vaccine Market Driver: Boost in Geriatric Population Numbers Propels Pertussis Vaccine Market Growth

Request Your Free Pertussis Vaccine Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Who Are the Top Companies Driving Innovation and Growth in the Pertussis Vaccine Market?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation.

What Key Trends Are Currently Impacting the Pertussis Vaccine Market’s Development?

Leading organizations in the pertussis vaccine market are focusing on the development of innovative medicines, securing necessary approvals to maintain their market standing. For example, in October 2022, GSK plc, a renowned UK pharmaceutical and biotechnology firm, announced that the U.S Food and Drug Administration (FDA) had approved BOOSTRIX. This vaccine is a blend of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap). It is designed for use during pregnancy to ward off pertussis, commonly known as whooping cough, in newborn babies. Delivered via a single injection into the upper arm muscle, Boostrix has proven safe and effective for expectant mothers and their infants. Moreover, it offers robust protection against pertussis, including its most severe presentations.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Which Key Segments Stand Out in Understanding the Composition of the Pertussis Vaccine Market?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Which Geographical Regions Are Pioneering Growth in the Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2024. The regions covered in pertussis vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Are the Defining Aspects of the Pertussis Vaccine Market Landscape?

The pertussis vaccine refers to a vaccine that protects against whooping cough (pertussis), which is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It is designed to stimulate the immune system to produce protective antibodies against the pertussis bacterium, thus reducing the risk of infection and its associated symptoms.

Browse Through More Similar Reports By The Business Research Company:

Pediatric Vaccine Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pediatric-vaccine-global-market-report

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Meningococcal Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: